All Stories

  1. Roles of GR Isoforms and Hsp90-binding Immunophilins in the Modulation of Glucocorticoid Biological Responses

    Article • Current Reviews in Clinical and Experimental Pharmacology, November 2023, Bentham Science Publishers

    Dr Mario D. Galigniana, Gisela Mazaira

  2. Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases

    Article • Current Drug Targets, September 2021, Bentham Science Publishers

    Gisela Mazaira, Dr Mario D. Galigniana

  3. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach

    Article • Anti-Cancer Agents in Medicinal Chemistry, April 2020, Bentham Science Publishers

    Sayan Dutta Gupta DST's Drugs and Pharmaceuticals Research Programme-, Dr Mario D. Galigniana, Gisela Mazaira

  4. Role of the Hsp90-Immunophilin Heterocomplex in Cancer Biology

    Article • Current Cancer Therapy Reviews, February 2020, Bentham Science Publishers

    Dr Alejandra G Erlejman, Dr Mario D. Galigniana

  5. Structural Characteristics of the TPR Protein- Hsp90 Interaction: A New Target in Biotechnology

    Article • April 2018, Bentham Science Publishers

    Dr Mario D. Galigniana, Ana Cauerhff

  6. Editorial (Thematic Issue: The Biology of Molecular Chaperones - Very Complex Activities for Quite Simple Proteins)

    Article • Current Protein and Peptide Science, April 2014, Bentham Science Publishers

    Dr Mario D. Galigniana

  7. Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52

    Article • Current Protein and Peptide Science, March 2014, Bentham Science Publishers

    Dr Mario D. Galigniana

  8. Molecular Basis of Mineralocorticoid Receptor Action in the Nervous System

    Article • CNS & Neurological Disorders - Drug Targets, September 2013, Bentham Science Publishers

    Dr Mario D. Galigniana

  9. Editorial: Steroid-Dependent Management of Biological Responses in The Nervous System

    Article • CNS & Neurological Disorders - Drug Targets, September 2013, Bentham Science Publishers

    Dr Mario D. Galigniana